Clinical Trial Update: A Phase I Study of MK-2206 in Combination With Standard Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors (MK-2206-003) [Phase 1]

View source ↗

Summary

Phase I study of MK-2206 in combination with standard chemotherapy in locally advanced or metastatic solid tumors has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• MK-2206 (MK-2206)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Locally Advanced, Metastatic Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2019-11-12